2171 — CARsgen Therapeutics Holdings Balance Sheet
0.000.00%
- HK$8.82bn
- HK$7.42bn
- CNY39.43m
Annual balance sheet for CARsgen Therapeutics Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,043 | 3,007 | 2,268 | 1,850 | 1,479 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.91 | 49 | 16.6 | 11.8 | 32.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,056 | 3,071 | 2,301 | 1,873 | 1,530 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 157 | 386 | 441 | 361 | 124 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,254 | 3,506 | 2,763 | 2,257 | 1,673 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 145 | 389 | 171 | 196 | 254 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2,930 | 509 | 290 | 456 | 616 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -1,676 | 2,997 | 2,473 | 1,802 | 1,057 |
Total Liabilities & Shareholders' Equity | 1,254 | 3,506 | 2,763 | 2,257 | 1,673 |
Total Common Shares Outstanding |